Regenerative urology clinical trials: An ethical assessment of road blocks and solutions

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 1, 2013, Pages 41-47

  Oerlemans, Anke J M ^a   Feitz, Wouter F J ^a   Van Leeuwen, Evert ^a   Dekkers, Wim J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL APPLICATION; CLINICAL EVALUATION; CLINICAL TESTING; CLINICAL TRIAL; EUROPEAN MEDICINES AGENCIES; EXPERIMENTAL STUDIES; FOOD AND DRUG ADMINISTRATION; GOLD STANDARDS; LONG-TERM EFFECTS; PATIENT POPULATION; RANDOMIZED CONTROLLED TRIAL;

DRUG PRODUCTS; PATIENT MONITORING; PHILOSOPHICAL ASPECTS; ROADS AND STREETS; TISSUE; TISSUE ENGINEERING;

PATIENT TREATMENT;

PLANT MEDICINAL PRODUCT;

CELL FUNCTION; CELL REGENERATION; CELL VIABILITY; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; GENE THERAPY; HUMAN; HUMAN TISSUE ENGINEERED PRODUCT; INFORMED CONSENT; LONG TERM CARE; MEDICAL DEVICE; MEDICAL ETHICS; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; RISK FACTOR; SOMATIC CELL THERAPY; TISSUE ENGINEERING; TISSUE REGENERATION; URINARY TRACT DISEASE; UROLOGY;

CHILD; CLINICAL TRIALS AS TOPIC; GUIDED TISSUE REGENERATION; HUMANS; NETHERLANDS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; UROGENITAL ABNORMALITIES; UROLOGY;

EID: 84873363678     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0136     Document Type: Review

References (39)

1. Williams, D.F. The Williams Dictionary of Biomaterials. Liverpool: Liverpool University Press, 1999.
2. The Committee for Advanced Therapies (CAT) and the CAT Scientific Secretariat. Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov 9, 195, 2010.
3. Messenger, M.P., and Tomlins, P.E. Regenerative medicine: a snapshot of the current regulatory environment and standards. Adv Mat 23, H10, 2011.
4. Ginty, P.J., Rayment, E.A., Hourd, P., and Williams, D.J. Regenerative medicine, resource and regulation: lessons learned from the remedi project. Regen Med 6, 241, 2011.
5. Williams, D.F. Tissue engineering: the multidisciplinary epitome of hope and despair. In: Paton, R., and McNamara, L., eds. Studies in Multidisciplinarity, vol. 3. Amsterdam: Elsevier, 2006. pp. 483-524.
6. Raya-Rivera, A., Esquiliano, D.R., Yoo, J.J., Lopez-Bayghen, E., Soker, S., and Atala, A. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 377, 1175, 2011.
7. Atala, A., Bauer, S.B., Soker, S., Yoo, J.J., and Retik, A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241, 2006.
8. Yoo, J.J., Olson, J., Atala, A., and Kim, B. Regenerative medicine strategies for treating neurogenic bladder. Int Neurourol J 15, 109, 2011.
9. Oerlemans, A.J.M., Rodrigues, H.C.M.L., Verkerk, M.A., van den Berg, P.P., and Dekkers, W.J.M. Ethical aspects of soft tissue engineering for congenital birth defects in children-What do experts in the field say? Tissue Eng Part B Rev 16, 397, 2010.
10. Oerlemans, A.J.M., van den Berg, P.P., van Leeuwen, E., and Dekkers, W.J.M. Ethical issues regarding the donation and source of cells for tissue engineering: a European focus group study. Tissue Eng Part B Rev 17, 229, 2011.
11. Wood, D., and Southgate, J. Current status of tissue engineering in urology. Curr Opin Urol 18, 564, 2008.
12. Atala, A. Tissue engineering of human bladder. Br Med Bull 97, 81, 2011.
13. Frimberger, D., Morales, N., Shamblott, M., Gearhart, J.D., Gearhart, J.P., and Lakshmanan, Y. Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology 65, 827, 2005.
14. Obara, T., Matsuura, S., Narita, S., Satoh, S., Tsuchiya, N., and Habuchi, T. Bladder acellular matrix grafting regenerates urinary bladder in the spinal cord injury rat. Urology 68, 892, 2006.
15. Feil, G., Daum, L., Amend, B., Maurer, S., Renninger, M., Vaegler, M. et al. From tissue engineering to regenerative medicine in urology-The potential and the pitfalls. Adv Drug Deliv Rev 63, 375, 2011.
16. ClinicalTrials.gov. Augmentation Cystoplasty Using an Au-tologous Neo-Bladder. August 9, 2011. http://clinicaltrials.gov/ct2/show/NCT00419120 (Accessed June 10, 2012).
17. Brévignon-Dodin, L. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU. Biomed Mater Eng 20, 121, 2010.
18. Hellman, K.B. Tissue engineering: translating science to product. In: Ashammakhi, N., Reis, R., and Chiellini, F., eds. Topics in Tissue Engineering, Vol. 4. Oulu, Finland: Ex-pertissues e-books, 2008, pp. 1-28.
19. Editors. European MEDICINES Agency, CAT Secretariat & US Food and Drug Administration. Regen Med 6, 90, 2011.
20. Kellathur, S.N., and Lou, H.X. Cell and tissue therapy regulation: worldwide status and harmonization. Biologicals 40, 222, 2012.
21. Lee, M.H., Arcidiacono, J.A., Bilek, A.M., Wille, J.J., Hamill, C.A., Wonnacott, K.M., Wells, M.A., and Oh, S.S. Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng Part B Rev 16, 41, 2010.
22. Hunziker, E.B. Tissue engineering of bone and cartilage. From the preclinical model to the patient. Novartis Found Symp 249, 70, 2003.
23. Rashid, S.T., Salacinski, H.J., Hamilton, G., and Seifalian, A.M. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 25, 1627, 2004.
24. Wakeman, D.R., Crain, A.M., and Snyder, E.Y. Large animal models are critical for rationally advancing regenerative therapies. Regen Med 1, 405, 2006.
25. Trommelmans, L., Selling, J., and Dierickx, K. Ethical issues in tissue engineering. European Ethical-Legal Papers N.7, Leuven, 2007.
26. Trommelmans, L., Selling, J., and Dierickx, K. Ethical reflections on clinical trials with human tissue engineered products. J Med Ethics 34, e1, 2008.
27. Emanuel, E.J., Wendler, D., and Grady, C. What makes clinical research ethical? JAMA 283, 2701, 2000.
28. European Commission Directorate C. Opinion on the state of the art concerning tissue engineering. Adopted by the Scientific Committee on Medicinal Products and Medical Devices on 1st Oct 2001. SANCO/SCMPMD/2001/0006Final. 2001.
29. US National Institutes of Health. Understanding Clinical Trials http://clinicaltrials.gov/ct2/info/understand (Accessed June 10, 2012).
30. Williams, D.F. A registry for tissue engineering clinical trials. Eur Med Device Technol 8, 2006.
31. Trommelmans, L., and Dierickx, K. Standard of care in clinical research with human tissue engineered products (HTEPs). Am J Bioeth 9, 44, 2009.
32. Curry, J.I., Reeves, B., and Stringer, M.D. Randomized controlled trials in pediatric surgery: could we do better? J Pe-diatr Surg 38, 556, 2003.
33. Black, N. Why we need observational studies to evaluate the effectiveness of healthcare. BMJ 312, 1215, 1996.
34. Farrokhyar, F., Karanicolas, P.J., Thoma, A., Simunovic, M., Bhandari, M., and Devereaux, P.J. et al. Randomized controlled trials of surgical interventions. Ann Surg 251, 409, 2010.
35. Trommelmans, L., Selling, J., and Dierickx, K. Informing participants in clinical trials with ex-vivo human tissue engineered products: what to tell and how to tell it? J Tissue Eng Regen Med 2, 236, 2008.
36. Hooijmans, C.R., Tillema, A., Leenaars, M., and Ritskes-Hoitinga, M. Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Lab Anim 44, 170, 2010.
37. Leenaars, M., Hooijmans, C.R., van Veggel, N., ter Riet, G., Leeflang, M., Hooft, L., van der Wilt, G.J., Tillema, A., and Ritskes-Hoitinga, M. A step-by-step guide to systematically identify all relevant animal studies. Lab Anim 46, 24, 2012.
38. FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. July 13, 2011. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm (Accessed March 1, 2012)
39. FDA Panel Recommends Reclassification of Surgical Mesh. http://www.auanet.org/content/documents/NET/FDA- Panel-Recommends- Reclassification-of-Surgical-Mesh% 20FINAL%20-2-.pdf (Accessed March 1, 2012)